{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.106.11.1036","meta":{"versionId":"5","lastUpdated":"2021-11-18T11:54:35.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036","version":"20210220","name":"Substance Use Disorder Treatment","status":"active","date":"2021-02-20T01:02:00-05:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","concept":[{"code":"G2067","display":"Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2068","display":"Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2069","display":"Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2070","display":"Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2071","display":"Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2072","display":"Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2073","display":"Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2074","display":"Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2075","display":"Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2076","display":"Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient\u0027s short-term goals and the tasks the patient must perform to complete the short-term goals; the patient\u0027s requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"code":"G2077","display":"Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"code":"G2080","display":"Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"code":"G2086","display":"Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month"},{"code":"G2087","display":"Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month"},{"code":"H0020","display":"Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"},{"code":"H0033","display":"Oral medication administration, direct observation"}]}]},"expansion":{"identifier":"urn:uuid:3bcc9e8a-7d26-4b7d-98db-6d7e56e9cb5f","timestamp":"2022-06-10T12:17:53-04:00","total":16,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2067","display":"Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2068","display":"Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2069","display":"Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2070","display":"Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2071","display":"Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2072","display":"Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2073","display":"Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2074","display":"Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2075","display":"Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2076","display":"Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient\u0027s short-term goals and the tasks the patient must perform to complete the short-term goals; the patient\u0027s requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2077","display":"Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2080","display":"Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2086","display":"Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2087","display":"Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"H0020","display":"Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"H0033","display":"Oral medication administration, direct observation"}]}}